Anthropic's Claude Science Targets Pharma Revenue
2h ago·0:00 listen·Source: Financial Times
Summary
Anthropic has launched Claude Science. This move aims to increase the company's revenue from the pharmaceutical sector. The details of Claude Science are available through various subscription options. These range from a trial offer of €1 for four weeks to premium digital access at €69 per month. There's also a Premium and FT Weekend Print option for €75 per month. These subscription models provide access to quality journalism and expert analysis. This initiative highlights how companies are seeking new revenue streams in specialized industries.
Read the full article on Financial Times →
This is an AI-generated audio summary. Always check the original source for complete reporting.